Analysis of Cytological Markers of Cellular Senescence in High‐Risk Cardiovascular Patients After COVID‐19
BioMed Research International · 2026-01 · 2026 (1)
DOI: 10.1155/bmri/5553698 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioMed Research International, online erschienen am 05.08.2026. Verfasst von Vitalii Kyryk und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Genetic and Regenerative Medicine, Strazhesko National Scientific Center of the National Academy of Medical Sciences of Ukraine, Kyiv, U…. Hauptthemen laut MEDLINE: COVID-19, Cellular Senescence, Acute Coronary Syndrome. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Ukraine.
Abstract (Originalsprache)
The purpose of this study was to investigate cytological markers of cellular senescence—including senescence‐associated β ‐galactosidase (SA‐ β ‐gal), senescence‐associated heterochromatin foci (SAHF), and parameters of the cytokinesis‐block micronucleus (CBMN) cytome assay—in peripheral blood samples from patients who had experienced an acute coronary syndrome accompanied by COVID‐19 (Group 2), compared with similar patients without COVID‐19 (Group 1). The relative proportion of SA‐ β ‐gal–positive leukocytes was approximately threefold higher in patients with a history of COVID‐19 compared with Group 1. Group 2 also demonstrated a significantly higher frequency of SAHF‐positive leukocytes. According to the CBMN assay, Group 2 showed a significantly higher relative content of binucleated leukocytes with micronuclei, as well as a higher frequency of apoptotic mononuclear cells. No significant differences were observed between the groups in the relative content of binucleated cells with nuclear buds or nucleoplasmic bridges, nor in the proportion of necrotic mononuclear cells. The cytokinesis‐block proliferation index was comparable between the groups. The findings of this retrospective study may indicate a detrimental long‐term effect of COVID‐19 on the manifestation of cellular senescence at the organismal level, and the evaluated markers may be informative for developing new prognostic strategies for this patient population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Genetic and Regenerative Medicine, Strazhesko National Scientific Center of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine.
- Laboratory of Pathophysiology and Immunology, Chebotarev State Institute of Gerontology of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine.
- Department of Cytology, Bogomoletz Institute of Physiology, National Academy of Sciences of Ukraine, Kyiv, Ukraine, nas.gov.ua.
- Department of Intensive Care and Resuscitation, Strazhesko National Scientific Center of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine.
ORCID-Profile: Vitalii Kyryk, Alina Ustymenko, Oleg Tsupykov, Oleksandr Skarzhevskyi, Oleksandr Parkhomenko
Förderung
- National Research Foundation of Ukraine
Zitieren
APA
Kyryk, V., Ustymenko, A., Tsupykov, O., Skarzhevskyi, O., & Parkhomenko, O. (2026). Analysis of Cytological Markers of Cellular Senescence in High‐Risk Cardiovascular Patients After COVID‐19. BioMed Research International, 2026(1). https://doi.org/10.1155/bmri/5553698
Vancouver
Kyryk V, Ustymenko A, Tsupykov O, Skarzhevskyi O, Parkhomenko O. Analysis of Cytological Markers of Cellular Senescence in High‐Risk Cardiovascular Patients After COVID‐19. BioMed Research International. 2026;2026(1). doi:10.1155/bmri/5553698
BibTeX
@article{Kyryk2026,
author = {Kyryk, Vitalii and Ustymenko, Alina and Tsupykov, Oleg and Skarzhevskyi, Oleksandr and Parkhomenko, Oleksandr},
title = {Analysis of Cytological Markers of Cellular Senescence in High‐Risk Cardiovascular Patients After COVID‐19},
journal = {BioMed Research International},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/bmri/5553698}
}
EUVIMED